T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Badger Meter
BMI
$5.24B
| $11.8M | ﹤0.01% |
63,237
+468
| +0.7% | +$87.2K |
|
1077
Illumina
ILMN
$15.4B
| $11.8M | ﹤0.01% |
112,652
-111,695
| -50% | -$11.7M |
|
1078
Match Group
MTCH
$8.97B
| $11.7M | ﹤0.01% |
385,725
-407,606
| -51% | -$12.4M |
|
1079
TAL Education Group
TAL
$6.81B
| $11.6M | ﹤0.01% |
1,091,581
+265,728
| +32% | +$2.84M |
|
1080
Avantor
AVTR
$8.66B
| $11.6M | ﹤0.01% |
549,276
-1,250,471
| -69% | -$26.5M |
|
1081
Fox Class A
FOXA
$25.9B
| $11.6M | ﹤0.01% |
337,947
+2,465
| +0.7% | +$84.7K |
|
|
BBOT
1082
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$796M
| $11.6M | ﹤0.01% |
1,130,677
| – | – |
|
1083
Lyell Immunopharma
LYEL
$253M
| $11.4M | ﹤0.01% |
393,618
+57,044
| +17% | +$1.65M |
|
1084
PennyMac Financial
PFSI
$6.42B
| $11.4M | ﹤0.01% |
120,067
+9,105
| +8% | +$861K |
|
1085
Reinsurance Group of America
RGA
$12.3B
| $11.3M | ﹤0.01% |
54,973
-88,205
| -62% | -$18.1M |
|
1086
Berkshire Hathaway Class A
BRK.A
$1.06T
| $11M | ﹤0.01% |
18
| – | – |
|
1087
Hasbro
HAS
$10.5B
| $11M | ﹤0.01% |
188,373
+7,250
| +4% | +$424K |
|
1088
Mueller Water Products
MWA
$3.96B
| $11M | ﹤0.01% |
614,826
-79,643
| -11% | -$1.43M |
|
1089
Pharvaris
PHVS
$1.52B
| $11M | ﹤0.01% |
585,271
-172,644
| -23% | -$3.25M |
|
1090
BorgWarner
BWA
$9.41B
| $10.9M | ﹤0.01% |
338,715
+10,143
| +3% | +$327K |
|
1091
Tenaya Therapeutics
TNYA
$202M
| $10.9M | ﹤0.01% |
3,513,724
+167,202
| +5% | +$518K |
|
1092
Synovus
SNV
$7B
| $10.9M | ﹤0.01% |
270,557
+39,701
| +17% | +$1.6M |
|
1093
Generac Holdings
GNRC
$10.7B
| $10.9M | ﹤0.01% |
82,111
+2,047
| +3% | +$271K |
|
1094
Petrobras Class A
PBR.A
$77B
| $10.8M | ﹤0.01% |
788,153
+179,000
| +29% | +$2.44M |
|
1095
Kaspi.kz JSC
KSPI
$16.2B
| $10.7M | ﹤0.01% |
82,960
+12,737
| +18% | +$1.64M |
|
1096
Solventum
SOLV
$12.9B
| $10.6M | ﹤0.01% |
200,064
+115,391
| +136% | +$6.1M |
|
1097
Janux Therapeutics
JANX
$1.41B
| $10.6M | ﹤0.01% |
252,358
+232,762
| +1,188% | +$9.75M |
|
1098
Dorian LPG
LPG
$1.38B
| $10.5M | ﹤0.01% |
249,311
+24,353
| +11% | +$1.02M |
|
1099
PBF Energy
PBF
$3.51B
| $10.5M | ﹤0.01% |
227,301
+37,839
| +20% | +$1.74M |
|
1100
Symbotic
SYM
$5.71B
| $10.2M | ﹤0.01% |
291,393
-78,253
| -21% | -$2.75M |
|